Suraksha Diagnostic Ltd (SURK)

Currency in INR
279.35
-0.45(-0.16%)
Real-time Data·
SURK is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
277.10279.80
52 wk Range
231.00449.00
Key Statistics
Bid/Ask
279.05 / 279.35
Prev. Close
279.8
Open
278
Day's Range
277.1-279.8
52 wk Range
231-449
Volume
3.14K
Average Volume (3m)
44.75K
1-Year Change
-
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
SURK Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
335.00
Upside
+19.92%
Members' Sentiments
Bearish
Bullish
ProTips
Trading at a high P/E ratio relative to near-term earnings growth

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Suraksha Diagnostic Ltd Company Profile

Suraksha Diagnostic Limited operates a chain of diagnostic centers in India. It offers pathology testing services, such as microbiology, serology, molecular biology, histopathology, cytopathology, clinical pathology, and haematology; genomics testing, including microarray, noninvasive prenatal, quantitative fluorescent polymerase chain reaction, fluorescence in situ hybridization, and karyotyping; and radiology testing that includes X ray, magnetic resonance imaging, computed tomography scan, USG, DEXA scan, OPG, and mammography. The company also provides Cardiology testing services comprises electrocardiogram, echocardiogram, stress test / treadmill test, wireless holter monitoring, colour doppler, peripheral doppler, and pulmonary function test; gastroenterology, such as upper and lower GI endoscopy, sigmoidoscopy, proctoscopy, colonoscopy, and proctosigmoidoscopy; and neurology testing services, including electroencephalogram, electromyography, and nerve conduction velocity test. In addition, the company provides dental, physiotherapy, immunology & rheumatology, eye, fetal care, ENT, and speciality clinics, as well as home doctor visit services. The company was founded in 1992 and is based in Kolkata, India.

Employees
1300
Market
India

Compare SURK to Peers and Sector

Metrics to compare
SURK
Peers
Sector
Relationship
P/E Ratio
45.6x55.5x−0.6x
PEG Ratio
4.651.040.00
Price/Book
6.3x7.5x2.6x
Price / LTM Sales
5.3x6.8x3.3x
Upside (Analyst Target)
19.7%18.4%41.4%
Fair Value Upside
Unlock4.0%6.0%Unlock

Analyst Ratings

0 Buy
1 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Neutral

Analysts 12-Month Price Target:

Average 335.00
(+19.92% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate

Earnings

Latest Release
Nov 10, 2025
EPS / Forecast
1.80 / --
Revenue / Forecast
787.00M / --
EPS Revisions
Last 90 days

SURK Income Statement

People Also Watch

792.00
SENO
+0.82%
2,363.20
INEH
-1.32%
214.57
DAMC
-0.11%
563.40
CARD
-0.72%

FAQ

What Stock Exchange Does Suraksha Diagnostic Trade On?

Suraksha Diagnostic is listed and trades on the India National Stock Exchange stock exchange.

What Is the Stock Symbol for Suraksha Diagnostic?

The stock symbol for Suraksha Diagnostic is "SURK."

What Is the Suraksha Diagnostic Market Cap?

As of today, Suraksha Diagnostic market cap is 14.57B.

What Is Suraksha Diagnostic's Earnings Per Share (TTM)?

The Suraksha Diagnostic EPS (TTM) is 6.06.

When Is the Next Suraksha Diagnostic Earnings Date?

Suraksha Diagnostic will release its next earnings report on 24 Feb 2026.

From a Technical Analysis Perspective, Is SURK a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Suraksha Diagnostic Stock Split?

Suraksha Diagnostic has split 0 times.

How Many Employees Does Suraksha Diagnostic Have?

Suraksha Diagnostic has 1300 employees.

What is the current trading status of Suraksha Diagnostic (SURK)?

As of 04 Dec 2025, Suraksha Diagnostic (SURK) is trading at a price of 279.35, with a previous close of 279.80. The stock has fluctuated within a day range of 277.10 to 279.80, while its 52-week range spans from 231.00 to 449.00.

What Is Suraksha Diagnostic (SURK) Price Target According to Analysts?

The average 12-month price target for Suraksha Diagnostic is INR335, with a high estimate of INR335 and a low estimate of INR335. 0 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Neutral. The stock has an +19.92% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.